US FDA approves BridgeBio's drug for rare heart condition
The U.S. Food and Drug Administration has approved BridgeBio's drug for a rare and deadly heart condition, the company said ...
Johnson threatens legal action to get COVID-19 vaccine data
U.S. Sen. Ron Johnson has threatened to issue a subpoena when he becomes chairman of the Permanent Subcommittee on ...
STAT21h
More beef in the gene editing space
In today's biotech news, Prime Editing's CEO promises aggressive defense of patents; Novartis acquires a gene editing startup ...
EconoTimes21h
CDC Reveals Alarming COVID Vaccine Update: 'Fewer Than 18% of Adults Are Getting the Shot'
Fewer than 18% of U.S. adults have opted to receive the newly updated COVID-19 vaccine, according to the latest data from the ...
Pfizer Stock Drops 10% In November On News Of Kennedy's HHS Nomination
Pfizer shares are trading lower by 10% in November. President-elect Donald Trump last week announced his intention to nominate Robert F. Kennedy Jr. to lead the HHS.
FiercePharma1d
As other Big Pharmas face local headwinds, Pfizer doubles down on China commitment with Zai Lab antimicrobial marketing pact
For Big Pharma, recent headlines out of China suggest multinational drugmakers are facing their share of challenges in the ...
Medscape1d
As GLP-1 Use Surges, Clinicians Weigh Benefits and Risks
GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will ...
bovnews1d
Pfizer Inc (PFE)’s Stock Surge: What You Need to Know
Wolfe Research has recently initiated Pfizer Inc (PFE) stock to Underperform rating, as announced on November 15, 2024, according to Finviz. Earlier, on October 25, 2024, Citigroup had resumed the ...